9-MTH group results (IFRS)
Feb 7 (Reuters)-
Mitsubishi Chemical Group Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2022 Dec 31, 2021 Mar 31, 2023
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 3.41 trln 2.90 trln 4.51 trln
(+17.4 pct) (+23.1 pct) (+13.5 pct)
Operating 48.62 218.24 71.00
(-77.7 pct) (-76.6 pct)
Pretax 39.21 208.18 57.00
(-81.2 pct) (-80.4 pct)
Net 17.04 122.13 28.00
(-86.0 pct) (-84.2 pct)
EPS Basic 11.99 yen 85.95 yen 19.69 yen
EPS Diluted 11.55 yen 79.06 yen
Ann Div 30.00 yen 30.00 yen
-Q2 Div 15.00 yen 15.00 yen
-Q4 Div 15.00 yen 15.00 yen
NOTE - Mitsubishi Chemical Group Corporation.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4188.T
Recent news on Mitsubishi Chemical
See all newsJapan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Japan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Brief: Mitsubishi Chemical Group Corp - Notice Regarding Commencement Of Consideration On Spin-Off Of Petrochemicals Business As A Wholly Owned Subsidiary
Bain-backed Tanabe Pharma targets three new drug launches a year in Japan
2025/26 group results (IFRS)